Claims

Genetic or chemogenetic enhancement of adult hippocampal neurogenesis does not improve baseline mood but can promote behavioural resilience to chronic stressors

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2022 · not yet checked against its sources · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? Bax deletion expanding adult-born neurons produced no baseline mood improvement but promoted resilience to chronic corticosterone and chronic social defeat stress; chemogenetic stimulation alleviated depressive-like behaviour after chronic mild stress. → Katherine L. Jones 2022

Evidence

Katherine L. Jones 2022

Katherine L. Jones, Mei Zhou and Dhanisha J. Jhaveri. (2022). Dissecting the role of adult hippocampal neurogenesis towards resilience versus susceptibility to stress-related mood disorders. npj Science of Learning 7:16. https://doi.org/10.1038/s41539-022-00133-y

q2 · i? · review · r2

Narrative review of the few gain-of-function studies. The review reports neural precursor cell-selective Bax deletion expanded adult-born neurons with no baseline mood improvement, while chemogenetic stimulation of adult-born neurons alleviated depressive-like behaviour following uncontrolled chronic mild stress.

"Although no baseline improvement in mood was found, enhancing the level of neurogenesis using this approach was shown to promote behavioural resilience to chronic corticosterone administration46 and chronic social defeat stress88."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-26
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.